Showing 29,261 - 29,280 results of 29,839 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 1.07s Refine Results
  1. 29261

    Table_6_Multiomic Fermentation Using Chemically Defined Synthetic Hydrolyzates Revealed Multiple Effects of Lignocellulose-Derived Inhibitors on Cell Physiology and Xylose Utilizat... by Yaoping Zhang (629825)

    Published 2019
    “…<p>Utilization of both C5 and C6 sugars to produce biofuels and bioproducts is a key goal for the development of integrated lignocellulosic biorefineries. …”
  2. 29262

    Table_4_Multiomic Fermentation Using Chemically Defined Synthetic Hydrolyzates Revealed Multiple Effects of Lignocellulose-Derived Inhibitors on Cell Physiology and Xylose Utilizat... by Yaoping Zhang (629825)

    Published 2019
    “…<p>Utilization of both C5 and C6 sugars to produce biofuels and bioproducts is a key goal for the development of integrated lignocellulosic biorefineries. …”
  3. 29263

    Image_1_Multiomic Fermentation Using Chemically Defined Synthetic Hydrolyzates Revealed Multiple Effects of Lignocellulose-Derived Inhibitors on Cell Physiology and Xylose Utilizat... by Yaoping Zhang (629825)

    Published 2019
    “…<p>Utilization of both C5 and C6 sugars to produce biofuels and bioproducts is a key goal for the development of integrated lignocellulosic biorefineries. …”
  4. 29264

    Image_1_Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels.PDF by Starlee Lively (620132)

    Published 2018
    “…<p>The cytokine, transforming growth factor β1 (TGFβ1), is up-regulated after central nervous system (CNS) injuries or diseases involving microglial activation, and it has been proposed as a therapeutic agent for treating neuroinflammation. …”
  5. 29265

    Table_3_Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels.PDF by Starlee Lively (620132)

    Published 2018
    “…<p>The cytokine, transforming growth factor β1 (TGFβ1), is up-regulated after central nervous system (CNS) injuries or diseases involving microglial activation, and it has been proposed as a therapeutic agent for treating neuroinflammation. …”
  6. 29266
  7. 29267
  8. 29268

    <i>hippo</i> defines the expression boundaries of epidermal markers. by Nídia de Sousa (4785606)

    Published 2018
    “…Scale bars: 150 μm (A); 50 μm (B); 25 μm (C). FISH, fluorescent in situ hybridization; <i>gfp</i>, <i>green fluorescent protein</i>; H3P, phospho-histone-H3-Ser10; RNAi, RNA interference; <i>vim</i>, <i>vimentin</i>.…”
  9. 29269

    Interaction between p33 replication protein and yeast oxysterol-binding Osh proteins. by Daniel Barajas (255452)

    Published 2014
    “…<p>(A) Co-purification of the yeast Osh6p and Osh7p proteins with the p33 replication protein. …”
  10. 29270

    Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn... by Esther M. Speer (5158913)

    Published 2018
    “…<div><p>Introduction</p><p>Neonatal inflammation, mediated in part through Toll-like receptor (TLR) and inflammasome signaling, contributes to adverse outcomes including organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which potently suppresses cytokine production in newborn cord blood, is a candidate neonatal anti-inflammatory agent. …”
  11. 29271

    Pathway analysis of arginine and proline metabolism. by Jie Meng (152665)

    Published 2013
    “…<p>The map displays selected steps from KEGG map00330, ‘Arginine and proline metabolism’. …”
  12. 29272

    Pathway analysis for taurine metabolism. by Jie Meng (152665)

    Published 2013
    “…<p>The map displays selected steps from KEGG map00430, ‘Taurine and hypotaurine metabolism’. …”
  13. 29273

    Pathway analysis of glycine metabolism. by Jie Meng (152665)

    Published 2013
    “…<p>The map displays selected steps from KEGG map00260, ‘Glycine, serine and threonine metabolism’. …”
  14. 29274
  15. 29275
  16. 29276

    Data_Sheet_1_Effect of breathing intervention in patients with COVID and healthcare workers.docx by Manjari Rain (10169170)

    Published 2022
    “…D-dimer was the primary outcome, which remained below 0.50 μg/ml (a cutoff value to define severity) in the COVID-positive yoga group (CYG) and decreased in the COVID-recovered yoga group (RYG) and the HCW yoga group (HYG) after intervention. …”
  17. 29277

    Data Sheet 1_The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells.pdf by Rita Rosenthal (285303)

    Published 2025
    “…Among other beneficial effects, EGCG was shown to be protective in inflammatory bowel disease (IBD), a condition associated with barrier dysfunction. …”
  18. 29278

    Image 3_The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells.tif by Rita Rosenthal (285303)

    Published 2025
    “…Among other beneficial effects, EGCG was shown to be protective in inflammatory bowel disease (IBD), a condition associated with barrier dysfunction. …”
  19. 29279

    Table_2_High Prevalence of Metallo-β-Lactamase-Producing Enterobacter cloacae From Three Tertiary Hospitals in China.xlsx by Yimei Cai (52714)

    Published 2019
    “…Notably, we identified the first NDM-1 and IMP-1 co-producing E. cloacae, carrying plasmids of several incompatibility (Inc) groups, including IncHI2, IncHI2A, and IncN. Most isolates showed decreased expression of ompC and/or ompF, and contained a broad distribution of ESBLs and AmpC β-lactamases. …”
  20. 29280

    Table_1_Physiological and Biomechanical Responses to Cross-Country Skiing in Varying Terrain: Low- vs. High-Intensity.docx by Trine M. Seeberg (5979200)

    Published 2021
    “…The terrain-dependent fluctuations did not differ between LI and HI for V.O2 (p = 0.50), whereas HR fluctuated less (p < 0.01) and displayed a time-dependent increase from Lap 2 to Lap 7 (7.8%-points, p > 0.01) during HI. …”